Using gene targeting in embryonic stem cells, we have generated mice w
ith one or two null p53 germ line alleles. Mice with both p53 alleles
inactivated are developmentally normal but highly susceptible to the e
arly development of spontaneous tumors. Initial studies were performed
in mice with a mixed inbred genetic background (75% C57BL/6 and 25% 1
29/Sv) (Donehower et al., Nature (London) 356, 215-221, 1992). To stud
y the effect of genetic background on tumorigenesis in p53-deficient m
ice, we have put the p53 null allele into a pure 129/Sv background and
monitored tumor development. 129/Sv mice with two p53 null alleles de
veloped tumors sooner than the mixed genetic background p53-deficient
animals. The most frequently observed tumor in p53 null mice of both g
enetic backgrounds was a malignant lymphoma. Because the 129/Sv strain
has a low incidence of lymphoma, the frequent occurrence of lymphomas
in all p53 null mice suggests that this particular tumor type may be
a direct result of p53 loss and not a result of a particular genetic b
ackground. In addition to malignant lymphomas, the 129/Sv p53-deficien
t mice showed an increased incidence of aggressive teratocarcinomas (8
of 18 tumor-bearing males), a tumor type rare in virtually all inbred
mice except for 129 strains. Thus, it appears that loss of p53 may ac
celerate a prior tumor predisposition and that genetic background can
play a role in mediating both the rate and spectrum of tumor developme
nt in these mice.